WHO Calls On African Governments To Ensure Strong Vaccine Safety Systems


To date, WHO considers that less than half of its Member States including most African countries have adequate capacity for vaccine safety

 A working dinner to discuss the Global Vaccine Safety Initiative (GVSI) policy was held on, 23 March, 2017 where about 80 participants including AU Member States and delegates, senior level officials from African Union Commission, partners, and distinguished invited guests met at The Multipurpose Hall of the African Union Commission in Addis Ababa, Ethiopia. This advocacy dinner meeting was organized by World Health Organization (WHO) in collaboration with the African Union Commission. The meeting aimed to enforce African countries to ensure strong vaccine safety systems. It also intended to provide the vision for a future where vaccine safety concerns are addressed in a rigorous and transparent fashion and share perspectives on 21st century approaches that are relevant to African Countries.
Related imageThe Global Vaccine Safety Initiative (GVSI) is a global transformative approach for quality immunization programmes which was launched in 2012. To date, WHO considers that less than half of its Member States including most African countries have adequate capacity for vaccine safety. It is in this context that the WHO brief was organized and called on the highest leadership in Africa to ensure strong vaccine safety system.Dr Margaret Agama-Anyetei from the African Union Commission in her welcoming remarks highlighted how vaccine has brought enormous benefits to the populations of Africa. Dr Margaret stated that “The eradication of smallpox, the gains made in the eradication of polio or the dramatic reductions in deaths of measles and epidemic meningitis are many successes that we have all witnessed.” She added that “Today more vaccines against more diseases, including malaria, dengue or Ebola are becoming available and new funding mechanisms allow for those vaccines to be used more widely in African countries.”On behalf of Dr. Akpaka A. Kalu, WHO Representative to Ethiopia Dr. Abebayehu Assefa Mengistu made an opening remark. Dr Abebayehu said that “The Global Vaccine Safety Initiative provides the mechanism to strengthen African countries regulatory authorities and immunization programs to ensure that everyone everywhere gets the safest vaccination possible.” He added that “Credible data and our ability to explain how existing safety systems protect the quality of our vaccination programs is the best approach to counter the impact of doubt or malicious statements and rumors.”

PSN, AHAPN, Decry Shortage of Pharmacists at Isolation Centres

The policy brief was presented by Dr. Patrick Zuber, World Health Organization-Head Quarters who highlighted major principles of vaccine safety initiative and why enhanced monitoring of the safety of immunization programs helps in increasing impact and benefits. He also discussed major recommendations of the policy which have been found key to the success of the vaccine safety system.

These recommendations include the need for dedicated human resources for vaccine safety for regulatory agencies and immunization programmes, national data system for monitoring vaccine safety, proactive communication about safety issues in support of all immunization policies and the commitment to international information exchange. During his presentation, Dr Patrick also emphasized the need for robust vaccine safety surveillance system. In addition, he indicated that increasing immunization coverage and adding new vaccines to the programmes call for the need to demonstrative capacity to monitoring the safety of these vaccines and to have stronger safety systems.

Meningitis: History and Causative Factors

Following the policy brief presentation, high level discussions were held, moderated by Ms. Margaret Ndomondo Sigonda from the New Partnership for Africa’s Development (NEPAD).

Finally, the session provided countries the opportunity to share their experience in addressing vaccine safety issues and indicated the perspectives on how the GVSI can add value to their immunization efforts.

Distributed by APO on behalf of World Health Organization (WHO).



Please enter your comment!
Please enter your name here